Peter Dannenbaum | VP, IR |
Ken Frazier | Chairman and Chief Executive Officer |
Rob Davis | Chief Financial Officer |
Dean Li | President of Merck Research Labs |
Mike Nally | Chief Marketing Officer |
Seamus Fernandez | Guggenheim Securities |
Andrew Baum | Citigroup |
Terence Flynn | Goldman Sachs |
Chris Schott | JPMorgan |
Louise Chen | Cantor |
David Risinger | Morgan Stanley |
Daina Graybosch | SVB Leerink |
Umer Raffat | Evercore ISI |
Steve Scala | Cowen |
Navin Jacob | UBS |
Gregg Gilbert | Truist Securities |
Mara Goldstein | Mizuho Securities |
Good morning. My name is Lara, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. Q4 Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise.